Naproxen and diflunisal in osteoarthrosis.
PM Brooks, MA Dougan, D Thomas, LJ Hills, PJ Smith
Rheumatol Rehabil | Published : 1982
Sixty-two patients with osteoarthrosis entered a 10-week double-blind cross-over trial of diflunisal and naproxen. Eight patients withdrew for drug-related reason, and seven for other reasons. There was no statistically significant difference in parameters of disease activity on each treatment period, but naproxen produced fewer withdrawals due to drug-related side-effects.